课题基金 / 基金详情

Developing a national Real-World Evidence decision making framework

Developing a national Real-World Evidence decision making framework
制定国家真实世界证据决策框架
批准号：
411907
负责人：
Chan Kelvin K
金额：
$0.73万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2020-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=411907&lang=en
关键词：
Cancer Decusion Making Drug Funding Health Services Research Health Technology Assessment Healthcare Policy Real-World Evidence Stakeholder Engagement

项目摘要

项目成果

Chan Kelvin K的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background: The Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) collaboration is a pan-Canadian team of researchers, clinicians, decision-makers, and others committed to establishing a framework for the use of real-world evidence (RWE)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada
A Multi-Province Approach to Real World Evidence Development for Cancer Drugs: A Case Study of Melanoma
Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada